This observational clinical analysis included 246 patients who underwent surgery for adjustable gastric banding (AGB), laparoscopic sleeve gastrectomy (LSG), or gastric bypass (GBP) between May 2005 and December 2008. The most frequent surgical procedure was for AGB (73.2% of patients). A thorough psychological evaluation of the patients was carried out, and pre-and post-operative psychological and dietary support was offered. A total of 111/120 (92.5%) AGB patients, 21/30 (70.0%) LSG patients and 8/36 (22.2%) GBP patients have been monitored for at least 1 year, and their mean weight losses (percentage excess weight loss) were 24.7 kg (52.4%), 46.0 kg (57.9%) and 40.5 kg (77.9%), respectively.
Introduction
Morbid obesity is a chronic, life-long, multifactorial, congenital disorder characterized by excessive fat deposits and associated medical, psychological, physical, social and economic problems and, as a result, presents a significant threat to health. 1 Excess weight puts additional stress on all parts of the body and increases the risk of diabetes, stroke, heart disease, kidney disease and gallbladder disease. 2 -4 Conditions such as high blood pressure and high cholesterol, which were once thought mainly to affect adults, are now commonly observed among obese children. 5 -7 Obesity may also increase the risk of some types of cancer, and obese people are more likely to develop osteoarthritis and sleep apnoea. 8 After smoking, obesity is the second leading cause of preventable death in the USA. 9
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Overall, a combination of genetic, environmental and behavioural factors may contribute to obesity.
Non-surgical treatments for obesity have relapse rates of up to 90%, irrespective of the choice of conservative treatment. 10 As early as 1991, the US National Institutes of Health issued a statement recognizing the lack of success with conservative forms of treatment, noting that operations to constrict or bypass the stomach were justified for fully informed and consenting patients and that it constituted an acceptable risk. 11 -13 In 1954, Kremen and Linner introduced jejuno-ileal bypass surgery. 14 -17 Modifications of the original procedures and the development of new techniques have lead to three basic approaches for bariatric surgery: (i) gastric restriction by gastric banding (verticalbanded gastroplasty and adjustable banding); (ii) gastric restriction with mild malabsorption (Roux-en-Y gastric bypass); and (iii) a combination of mild gastric restriction and malabsorption (duodenal switch). 4, 18, 19 Bariatric surgery can be performed by both open and laparoscopic techniques, although the laparoscopic technique has become the more popular approach. 13,20 -22 We began using bariatric surgery in some demonstrative procedures at the University Clinical Centre Ljubljana, Slovenia, early in 2000. We then began routinely performing surgery for obesity at Slovenj Gradec General Hospital, Slovenj Gradec, Slovenia in 2005, and the present observational clinical analysis reports the pre-operative assessment, surgical procedures and postoperative follow-up of the patients who have undergone bariatric surgery in this institute.
Patients and methods

BARIATRIC PROCEDURES
Three well-established bariatric surgical procedures have been used routinely in performing surgery for obesity at Slovenj Gradec General Hospital since 2005: (i) Roux-en-Y gastric bypass (GBP), (ii) adjustable gastric banding (AGB) and (iii) laparoscopic sleeve gastrectomy (LSG). These will now be briefly described and reviewed.
Roux-en-Y gastric bypass
The Roux-en-Y GBP procedure is currently the most commonly used procedure in bariatric surgery and has become the gold standard against which other procedures are compared. Roux-en-Y GBP has both a restrictive component and a malabsorptive component, and leads to a substantial degree of post-operative dietary restriction. The restrictive element of Roux-en-Y GBP involves the creation of a small gastric pouch (approximately 20 ml in volume) with a small outlet that, on distension by food, causes a sensation of satiety. In addition, Roux-en-Y GBP provides a small-to-moderate degree of intentional malabsorption due to the separation of food (which passes through the alimentary limb of the 'Y' of the GBP) from the biliopancreatic secretions (which pass through the biliopancreatic limb of the 'Y'). The degree of malabsorption can be adjusted by modifying the length of the alimentary and biliopancreatic limbs.
Roux-en-Y GBP is a major elective surgical procedure. Nevertheless, although rarely required, it can be reversed. As with all bariatric procedures, however, total reversal without conversion to another bariatric procedure is almost always followed by a return to morbid obesity. Laparoscopic Rouxen-Y gastric bypass results in substantial weight loss and has been shown to resolve > 80% of cases of type 2 diabetes. 23 In fact, it has been suggested that this bariatric operation should be considered the standard-of-care for morbidly obese type 2 diabetics. 4 There are, however, several risks B Breznikar, D Dinevski Review of outcomes following bariatric surgery associated with this procedure, including mortality (1 -2% of patients) mainly due to pulmonary embolism or gastrointestinal leak, wound infections, gastrojejunal stomal stricture, marginal ulcers, internal hernia, roux limb ischaemia, blow out of stomach remnants, and long-term nutrient deficiencies (e.g. vitamin B 12 , folate, iron). 24 -27 Vitamin D deficiency and elevated parathyroid hormone are common following Roux-en-Y GBP and progress over time. 28 There is a significant incidence of secondary hyperparathyroidism in short limbed Rouxen-Y GBP patients, even those with vitamin D levels ≥ 30 ng/ml, suggesting selective calcium malabsorption; calcium malabsorption is, therefore, inherent in Roux-en-Y GBP. 29, 30 Careful calcium and vitamin D supplementation and long-term screening are, therefore, necessary to prevent deficiencies and the sequelae of secondary hyperparathyroidism.
Adjustable gastric banding
The device used in AGB surgery consists of an adjustable inflatable band placed around the proximal part of the stomach. This creates a small gastric pouch (approximately 15 ml in volume) and a small stoma. Band restriction is adjusted by adding or removing saline from the inflatable band by a reservoir system of saline attached to the band that is accessed through a port, which is attached by a catheter to the band. The port is placed subcutaneously in the anterior abdominal wall after the band is secured around the stomach. Adjustment of the band through the access port is an essential part of laparoscopic AGB therapy. Appropriate adjustments, performed up to six times annually, are critical for successful outcomes. Patients must chew food thoroughly to allow it to pass through the band. Adjusting the inflation of the cuff changes the size of the opening through which food passes but does not change the size of the gastric pouch; deflation of the cuff is useful when the outlet is obstructed. The percentage excess weight loss (EWL) after laparoscopic AGB can be expected to be about 50 -60% in approximately 2 years. AGB can be completely reversed, which involves removal of the band, tubing and port. Laparoscopic AGB is a safe and feasible technique with specific indications in both moderately obese and highly obese patients who are not fit enough to undergo more invasive procedures. In patients with mildto-moderate obesity, laparoscopic AGB appears to be significantly more effective than non-surgical therapies in producing weight loss, resolving the metabolic syndrome and improving quality of life outcomes. 31 -33 Laparoscopic sleeve gastrectomy The LSG procedure involves resection of the stomach along the greater curvature. For high-risk obese patients seeking gastric bypass, it may be safer and more effective first to conduct LSG and then to perform the higher morbidity, higher mortality Roux-en-Y GBP procedure at a later date. 31 LSG has, therefore, been advocated as the first of a two-stage procedure for high-risk, superobese patients 34, 35 and, more recently, LSG has also been studied as a single-stage procedure for weight loss in the morbidly obese. 36 Initial studies have shown that LSG produces excellent excess weight loss that was comparable with laparoscopic Roux-en-Y GBP, with a very low incidence of major complications and death. 37 The data seem to indicate, however, that LSG only causes short-term weight loss in most cases, so follow-up using the Roux-en-Y GBP procedure is likely to be required. Nevertheless, LSG causes weight loss in B Breznikar, D Dinevski Review of outcomes following bariatric surgery many patients and makes them better candidates for subsequent Roux-en-Y GBP procedure.
PATIENT POPULATION
This observational clinical study involved obese patients who underwent surgery using the Roux-en-Y GBP, AGB or LSG procedures at Slovenj Gradec General Hospital, Slovenj Gradec, Slovenia from May 2005 until December 2008.
PRE-OPERATIVE ASSESSMENTS
Patients were considered candidates for surgery if they met one of the following criteria: body mass index (BMI) > 40 kg/m 2 or a BMI of 35 -40 kg/m 2 plus one of the obesity-associated comorbidities (diabetes, hypertension, cardiopathy, sleep apnoea, osteoarthritis and asthma). To be candidates for bariatric surgery, patients should have attempted, without success, to lose an appropriate amount of weight through supervised diet changes. Patients also had to comply with post-operative diet and exercise regimens. Contraindications for bariatric surgery included substance abuse, major psychiatric disorder and end-stage organ disease (e.g. hepatic, cardiac and pulmonary). Upper and lower age restrictions for bariatric surgery were 18 and 61 years of age, respectively, as recommended by the Society of American Gastrointestinal Endoscopic Surgeons. 38 The diversity of clinical and occult obesityrelated comorbidities necessitates a multidisciplinary team approach in the preoperative evaluation of the morbidly obese patient in order to enhance post-operative outcomes. Pre-operative cardiac, pulmonary, psychiatric and endocrine evaluations helped to identify and exclude patients who may not benefit from surgery, while optimizing selection of those patients who are considered to be potentially good candidates. Preoperative nutritional consultation helped in obtaining a detailed diet history and in explaining the pre-and post-operative diet protocols. At Slovenj Gradec General Hospital, a thorough pre-operative psychological evaluation is carried out in order to inform decision making regarding the best surgical procedure for each patient; e.g. if the patient is not sufficiently motivated or has a strong obsessive-compulsive component they would not be considered to be a good candidate for a gastric banding procedure as this procedure requires a high level of co-operation and self-control on the part of the patient.
POST-OPERATIVE ASSESSMENTS AND FOLLOW-UP
Following surgery, patients were monitored for weight loss, BMI and percentage EWL. Percentage EWL was calculated as (weight loss/excess weight) × 100.
Following surgery, patients were required to remain on a high-protein, low-fat diet and to supplement their diet with multivitamins, iron and calcium. Ursodiol may be given to minimize the risk of developing gallstones during the period of acute weight loss. Patients were required to modify their eating habits by avoiding chewy meats and other foods that may inhibit normal emptying of their stomach pouch. Nutritional and metabolic blood tests were performed on a frequent basis (at 6 and 12 months after surgery, and annually thereafter).
Patients could also attend a voluntary monthly support group meeting, which they were expected to attend for at least 1 year after they had reduced their body weight, and where their clinical progress and quality of life were monitored using the Bariatric Analysis and Reporting Outcome System (BAROS) which includes the Moorehead- Inserted AGB  180  152  133  120  61  9  Functioning AGB  171  143  124  111  51 6 a a One male patient with a functioning AGB who no longer attends the clinic has been lost to follow-up and was not included in the data analysis.
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Ardelt Quality of Life Questionnaire. 39 This system has five potential outcomes (failure, fair, good, very good, excellent) based on a scoring system of up to three points for each of EWL, change in medical condition (including complications and the need for reoperation) and quality of life; up to three points can also be deducted for complications and re-operations. 
Results
PATIENTS AND BARIATRIC PROCEDURES
ADJUSTABLE GASTRIC BANDING
We began carrying out AGB at Slovenj Gradec General Hospital in May 2005. The number of patients with functioning AGBs relative to the number of patients who have undergone AGB surgery stratified by length of follow-up is shown in Table 1 . Not all patients were followed up as some had the gastric band removed early after surgery or were lost to follow-up. Continued improvements in mean weight reduction ( Fig. 1 ) and mean EWL (Fig. 2) were observed over the 3 years following AGB surgery. A total of 111/120 (92.5%) of the AGB-treated patients, comprising 98 females and 13 males, have been monitored for at least 1 year after the operation. They lost a mean of 24.7 kg body weight (range -1. The mean EWL was 66.9% (range -11.2 -126.0%): female mean EWL 68.5% (range -11.2 -126.0%); male mean EWL 52.7% (range 40.5 -63.5%).
Eight out of nine patients, six females and two males, have been monitored for ≥ 3 years post-operatively (one male patient no longer attends the clinic and has been lost to follow-up). Of these, three had second operations -two females and one maleleaving five patients, all female, for analysis. These female patients lost a mean of 30.3 kg (range 16.0 -50.0 kg). The mean EWL was 62.6% (range 31.5 -94.2).
Mean BMI among the AGB patients before the operation was 41.9 kg/m 2 . After 1 year mean BMI was 34.0 kg/m 2 , after 2 years it was 30.8 kg/m 2 and after 3 years it was 31.8 kg/m 2 (Fig. 3) .
In total, out of the original 120 AGB patients monitored for ≥ 1 year, nine underwent reoperation: six had band removal without replacement, two underwent LSG and one had GBP (Tables 2  and 3 ). Three of these re-operations were performed among the eight patients who were followed up for ≥ 3 years: one to remove the AGB due to dilation of the pouch due to band slippage 2 years after the initial operation, and two to perform LSG because of insufficient reduction in body weight 1 and 3 years after the initial operation. These procedures were all carried out in different patients. In addition to these nine original patients, GBP was also performed on two patients transferred from another institution: one because of failed AGB and one because Obesity-related comorbidities and their outcomes for the patients treated with AGBs are shown in Tables 4 and 5, respectively. There were no cases of peri-operative mortality, pulmonary embolism, stomach wall lesions, or haemorrhage. Early complications that occurred within 2 months of the operation were: one case of a band that was too tight (where the band was removed 1 week after initial surgery); one of intra-abdominal abscess (where the band was removed 2 months after initial surgery); and one case of outlet obstruction (where the band was removed 5 weeks after initial surgery). To date, AGB slippage has also occurred in two patients (late complications). A total of nine AGBs have been removed ( Table 2) : seven among the first 50 procedures that were carried out, two from procedures 51 -100 and none from procedures 101 -180 ( Table 3 ). The reasons for removal were: that the AGB was too tight (one case); outlet obstruction (one case); AGB slippage (two cases); insufficient weight loss (three cases); personal psychological reasons (one case); and intra-abdominal abscess (one case). In two patients, LSGs were performed after they had insufficient weight loss with an AGB and, in three patients, leakage of the stapler line occurred.
LAPAROSCOPIC SLEEVE GASTRECTOMY
Comorbidities and their outcomes in the patients who underwent LSGs are shown in Table 6 . Hypertension  27  12  11  4  Diabetes  22  6  14  2  Hyperlipidaemia  13  2  8  3  Orthopaedic problems  29  16  12  1  Sleep apnoea  2  2  0  0  Asthma  10  3  5  2  Hypothyroidism  5  2  3  0  Gastro-oesophageal reflux  disease  5  4  1  0  Cardiopathy  3  1  1  1  Infertility  3  1  2  0  Hiatal hernia  6  4  2  0  Depression  7  5 2 0 a Some patients had more than one comorbidity prior to undergoing surgery.
GASTRIC BYPASS SURGERY
TABLE 4:
The number of patients with obesity-related comorbidities (n = 79), stratified according to their pre-operative body mass index (BMI), amongst those who underwent the adjustable gastric banding procedure B Breznikar, D Dinevski Review of outcomes following bariatric surgery was transferred from another institution following failure of AGB.
Comorbidities and their outcomes in the patients who underwent Roux-en-Y GBP surgery are shown in Table 7 .
COMPLICATIONS
Two major complications occurred following GBP; one case of stenosis of the entero-entero anastomosis and one case of ileus due to adhesions. In the first case, the anastomosis was enlarged with another firing of a 45 mm white cartridge. In the second, an adhesiolysis was performed. There was also one minor complication, gastrointestinal bleeding (haematohesia), which required a transfusion of two units of blood.
PATIENT OUTCOMES
In total, 149 patients across all three of the a It was not possible to follow all baseline comorbidities in all patients, therefore, only diabetes, hypertension and hyperlipidaemia were followed up over the post-operative period. b Eight patients with hypertension for whom data were available did not improve or resolve. c Four patients with hyperlipidaemia for whom data were available did not improve or resolve. 
Discussion
The results of the present study are comparable with those of previously published studies. 13,19,40 -42 There was a noticeable difference between the postoperative outcomes in patients who underwent surgery early in the study period, when a less strict interdisciplinary approach was applied, than in the outcomes achieved after more experience had been gained in using the techniques. Several of the first 20 AGB procedures were not successful because of insufficient pre-operative psychological and dietary treatment. For example, our first patient had psychological problems that were not recognized; we did not have a psychologist of our own at that time. The patient was willing to co-operate, but did not report that her son was a drug user or that her husband was an alcoholic. Due to this psychological crisis, she struggled unsuccessfully to control her weight and 2 years after the initial AGB she underwent LSG. Our second patient was unable to change his eating habits, which resulted in dilation and slippage of the AGB; it is felt that this outcome would now have been predicted. Another early patient ate too much, too quickly and, as a result, 5 weeks after the operation an outlet obstruction occurred and the AGB had to be removed. Failures that occurred among the first 10 patients could now probably be prevented with a good psychological evaluation.
Patients selected to undergo AGB should be very motivated and willing to co-operate. If the patient has several obsessivecompulsive elements in their character, then good results cannot be expected. Frequent monitoring after surgery and participation in a support group are very important, as is immediate emptying of the band if necessary.
It has been shown in a randomized study that laparoscopic AGB is superior to open gastric banding with regard to hospital stay and re-admissions. 13, 43 The AGB procedure is also usually reported to be associated with a low peri-operative complication rate and a very low mortality rate. 9, 44 The mean EWL after ≥ 2 years has been reported to be between 45% and 65%, which compares with the present study that showed a mean EWL of 66.9%. 42, 45, 46 Commonly reported long-term AGB complications are slippage with or without pouch dilatation, erosion (migration of the band into the stomach), AGB or port infection and leaks from the AGB, port or connecting tube. 47 -49 Overall, late morbidity affected between 6% and 25% of the patients in a series that included > 100 patients. 9, 44, 49 The frequency of each of these complications varied among the series; for example, AGB slippage occurred at rates between 0.6% and 20%, AGB erosion at rates between 0% and 11%, and leaks at rates between 1.4% and 26%. 47 -49 There were two cases of slippage, no migrations and no leaks among 120 patients who underwent the AGB procedure in the present study and were monitored for > 1 year. Late complications of these types can lead to re-operations in up to 20% of patients. 9, 42, 47 The re-operation rate for AGB patients in the present study was 7.5% (nine of the 120 patients who successfully underwent AGB and were followed up). We were satisfied with our procedures because there were no fatalities, stomach wall lesions, pneumothorax, haemorrhages, port system complications or wound infections compared with the following rates reported in the literature: fatalities up to 2.1%, stomach wall lesions up to 3.5%, haemorrhage up to 2.0%, and port or band system complications up to 10.4%. 8 The Roux-en-Y GBP procedure has generally been considered the gold standard based on the availability of long-term results that have achieved an EWL of approximately 70% over 7 -10 years. 50 -52 The correction of comorbid conditions has been reported for diabetes mellitus (83%), hypertension (69%), gastric reflux (100%), urinary stress incontinence and degenerative joint disease. 53 -56 Flum and Dellinger 57 reported significant improvement in survival for a group of patients treated with surgery compared with conventional treatment. Cost analysis showed that recovery of the procedure cost was achieved in 12 months. 58 When one considers the improvements in life expectancy, resolution of severe chronic disease, improvement in quality of life and reduction in the risk of cancer, there is hardly a procedure or medication in the history of medicine that can equal the Roux-en-Y GBP procedure.
Compared with published results, our programme of laparoscopic bariatric surgery has been successful. Although significant complications have occurred in a few patients (LSG leaks) the rate of complications has decreased progressively with experience and the implementation of improved surgical techniques and new materials. Weight loss has been acceptable and resolution of comorbidities has occurred as anticipated. With our increased experience, we are now performing an increasing number of Roux-en-Y GBP procedures.
In conclusion, bariatric surgery has proven to be the best treatment for morbid obesity. The AGB procedure is associated with the fewest complications but it is not appropriate for all patients; good preoperative psychological evaluation has been shown to be necessary for successful outcomes. Super-obese patients have a high risk of peri-operative complications and AGB is not necessarily the best choice in these patients; in such cases, we prefer to use LSG. The results suggest that surgeons practising bariatric surgery should make the effort to learn the skills needed to perform laparoscopic Roux-en-Y GBP, as it is likely to become the standard-of-care for the surgical treatment of obesity. Good results can be expected with an interdisciplinary approach after an initial learning curve and postoperative outcomes are significantly better when patients are regularly monitored. Our study showed that the outcomes are best when patients participate in a support group guided by a psychologist, particularly among patients who underwent AGB.
